Bayesian Optimization–Enhanced Machine Learning for Osteosarcoma Risk Stratification Based on Sphingolipid Metabolism
Human Mutation · 2025
DOI: 10.1155/humu/2904964 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, 2025. Verfasst von Yujian Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Osteosarcoma, Machine Learning, Sphingolipids, Bone Neoplasms. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Heterogenized sphingolipid metabolism (SM) drives osteosarcoma tumorigenesis and its tumor‐promoting microenvironment. State‐of‐the‐art bioinformatic tools, such as machine learning, are essential for dissecting the prognostic value of SM by investigating its molecular and cellular mechanisms.
Methods
A tailored machine learning pipeline was established by integrating Cox regression, 5‐fold cross‐validation, Elastic Net, eXtreme Gradient Boosting (XGBoost), and Bayesian optimization (for hyperparameters tuning) to foster an SM Elastic Net‐XGBoost (SNEX) prognostic model, interpreted by the Shapley additive explanations (SHAP) algorithm. The alterations in molecular pathways and immune microenvironment–driven unfavorable prognosis of SNEX‐identified high‐risk osteosarcoma were further investigated. The SNEX predicted results have also been clinically and experimentally validated.
Results
We identified 22 critical SM prognostic genes for Bayesian‐optimized SNEX. This model provided outstanding estimates of the prognoses of osteosarcoma patients (C‐index of 1.000). Its robustness was confirmed in the independent test set with a high area under the curve (AUC) of 0.875 at 1 year, 0.930 at 3 years, and 0.930 at 5 years. SNEX also significantly outperformed all previous genetic prognostic signatures with a significantly higher net benefit of decision curves and higher AUCs. ACTA2 was the most pivotal gene critical to the negative prediction of SNEX, while BNIP3 was for positive prediction. Mechanistically, SNEX‐identified high‐risk osteosarcoma suffered unfavorable prognoses due to dysregulation of many critical metabolic/inflammatory/immune biologic processes and immunosuppressive microenvironment, with reduced infiltration of 14 types of immune cells (macrophages, CD8+ T cells, NK cells, etc.). Notably, SNEX highlighted TERT as the most remarkable SM prognostic gene. Clinical osteosarcomas with high expression of TERT exhibited more significant malignant characteristics than others, as evidenced by their higher proliferation efficiency. In addition, all the experiments in vitro and in vivo validated that inhibiting TERT abundance reduces the proliferation, invasion, and migration capabilities of osteosarcoma cells.
Conclusions
This study is a first‐hand report employing a tailored machine‐learning pipeline for dissecting the prognostic value and roles of SM in osteosarcoma. The present study fostered a SNEX for risk‐stratification with outstanding accuracy and offered deep insights into SM‐mediated pathways and microenvironment dysregulation in osteosarcoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Primary Care and Public Health, School of Public Health, Faculty of Medicine, Imperial College London, London, UK.
- Clinical Research Design Division, Clinical Research Center, Breast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen Univer…
- Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, China.
ORCID-Profile: Yujian Zhong, Ruyuan He, Queran Lin, Fei Peng, Wenyi Jin
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhong, Y., He, R., Jiang, Z., Lin, Q., Peng, F., & Jin, W. (2025). Bayesian Optimization–Enhanced Machine Learning for Osteosarcoma Risk Stratification Based on Sphingolipid Metabolism. Human Mutation. https://doi.org/10.1155/humu/2904964
Vancouver
Zhong Y, He R, Jiang Z, Lin Q, Peng F, Jin W. Bayesian Optimization–Enhanced Machine Learning for Osteosarcoma Risk Stratification Based on Sphingolipid Metabolism. Human Mutation. 2025. doi:10.1155/humu/2904964
BibTeX
@article{Zhong2025,
author = {Zhong, Yujian and He, Ruyuan and Jiang, Zewen and Lin, Queran and Peng, Fei and Jin, Wenyi},
title = {Bayesian Optimization–Enhanced Machine Learning for Osteosarcoma Risk Stratification Based on Sphingolipid Metabolism},
journal = {Human Mutation},
year = {2025},
doi = {10.1155/humu/2904964}
}
EUVIMED